Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 3, 2010-01 ,pp. : 184-195

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension

By Chen C   Chen H   Yang K   Yu W   Liao H   Huang D  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 3, 2006-05 ,pp. : 245-247

Informa Healthcare

Access to resources Recommend Favorite

Development of Monocrotaline-Induced Pulmonary Hypertension Is Attenuated by a Serotonin Receptor Antagonist

By Miyata M.   Ito M.   Sasajima T.   Ohira H.   Sato Y.   Kasukawa R.  

Lung, Vol. 178, Iss. 2, 2000-03 ,pp. : 63-73

Springer Publishing Company

Access to resources Recommend Favorite

Acute Coronary Artery Injury in Dogs Following Administration of CI-1034, an Endothelin A Receptor Antagonist

By  

Cardiovascular Toxicology, Vol. 6, Iss. 1, 2006-03 ,pp. : 25-38

Humana Press, Inc

Access to resources Recommend Favorite

Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension

By Behzadnia Neda   Najafizadeh Katayoun   Sharif-Kashani Babak   Dameshghi Davoud   Shahabi Payman  

Heart and Vessels, Vol. 25, Iss. 4, 2010-07 ,pp. : 313-318

Springer Publishing Company

Access to resources Recommend Favorite